Increased IFN- synthesis by T cells from patients on imatinib therapy for chronic myeloid leukemia

By Jorg M Aswald  

Cytokines, Cellular & Molecular Therapy, Vol. 7, Iss. 4, 2002-12 ,pp. : 143-149

Informa Healthcare

Access to resources Recommend Favorite

Methylation analysis of the DAPK1 gene in imatinibresistant chronic myeloid leukemia patients

By  

Oncology Letters, Vol. 9, Iss. 1, 2015-01 ,pp. : 399-404

Spandidos Publications

Access to resources Recommend Favorite

Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia (B-CLL): Comparison of indolent and progressive disease

By Kiaii Shahryar   Choudhury Aniruddha   Mozaffari Fariba   Kimby Eva   Österborg Anders   Mellstedt Håkan  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 291-302

Humana Press, Inc

Access to resources Recommend Favorite

In vitro effects of imatinib on CD34+ cells of patients with chronic myeloid leukemia in the megakaryocytic crisis phase

By              

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 791-796

Spandidos Publications

Access to resources Recommend Favorite

Pharmacokinetic–pharmacodynamic relationship of bosutinib in patients with chronic phase chronic myeloid leukemia

By Hsyu Poe-Hirr   Mould Diane   Upton Richard   Amantea Michael  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 209-218

Springer Publishing Company

Access to resources Recommend Favorite